Protein Dynamics and Allostery II
Elke Schultz‐Thater,Emanuele Trella,Sylvie Miot,Tao Yao,Tao Jiang,Deyu Pan,Xu Zx,Zhou P. Rsc Adv,Saurabh Gautam,Sandip Karmakar,Somnath Maji,Ramya Billur,Muriel C. Maurer
2016-01-01
Abstract:The key pathogen responsible for these disorders generally consists of fibersdominated with b-sheet structural conformation known as amyloid. Theseare formed either via nucleation dependent or seeded polymerization process.Silkfibroinproteiniscommonlyusedfordevelopingbiomaterials[1].Althoughingeneral,silkfibroinhasbeenacceptedasbiocompatibleprotein,butitconsistsof repeated sequences of AHGGYSGY and GAGVGAGYG, similar to prionoctapeptide PHGGGWGQ sequence and VGGAVVAGV amyloid-b peptide,respectively [2, 3]. In addition, these proteins share a similar mechanism forfibril formation. These remarkable similarities between silk fibroin and amy-loid-b peptide, make it as good choice to serve as a model protein for studyingthe aggregation inhibition studies. An addition of apposite excipients such ascurcumin and b-cyclodextrin can either restrict or inhibit the aggregation pro-cessofproteinspartiallyorcompletely.Recently,astudyhasproventhatcock-tail of curcumin and b-cyclodextrin could be utilized as a potent inhibitor ofamyloidformationbytheParkinson’sdiseaseproteina-synuclein[4].Inthepre-sentwork,wehaveusedthealloyofcurcuminandb-cyclodextrintopreventtheaggregation in silk fibroin, which can further be explored as a suitable drug forpreventing the amyloid plaques responsible for Alzheimer’s disease.References[1] Bhattacharjee M, Schultz-Thater E, Trella E, Miot S, Das S, Loparic M,et al. Biomaterials 2013;34:8161-71.[2]ZongXH,ZhouP,ShaoZZ,ChenSM,ChenX,HuBW,etal.Biochemistry2004;43:11932-41.[3] Yao T, Jiang T, Pan D, Xu ZX, Zhou P. Rsc Adv 2014;4:40273-80.[4] Gautam S, Karmakar S, Bose A, Chowdhury PK. Biochemistry2014;53:4081-3.1094-Pos Board B71A Minimalistic Kinetic Model for Amyloid Self-AssemblySrivastav Ranganathan, Samir K. Maji, Ranjith Padinhateeri.DepartmentofBiosciencesandBioengineering,IITBombay,Mumbai,India.Amyloid aggregation is a phenomenon in which proteins/peptides self-assemble into highly ordered structures that are associated with diseases (e.g.Alzheimer’s and Parkinson’s) as well as several native biological functions.A wide range of proteins/peptides can form these structures while displayingremarkable phenomenological similarities, both structural and kinetic. Thus,there is a need for a unifying frameworkthat would enable a better understand-ingofthephenomenonofamyloidformation.Inthecurrentwork,wedevelopacoarse-grained model for amyloid formation that accounts for experimentallyknown phenomenon like polymerization, depolymerization (under differentpolymer-states) and the conformational transition of monomers during aggre-gation. The model is analytically solvable, and can be simulated for timescalesandlengthscalesthatarebiologicallyrelevant.Ourmathematicalmodelandki-netic Monte carlo simulations shed light on the vital signatures of amyloidgrowth, including a plausible explanation for the concentration-independenceof fibril growth velocities at large free-monomer concentrations. Interestingly,our simulations also reveal the relationship between the heterogeneity in fila-ment lengths (variances) and the rate of conformational transition. The lengthfluctuation data suggest that an increased rate of conformational transition notonly alters the extent of fluctuation in filament lengths, but also the timescalesat which the heterogeneity is maximum. Using our analytical expressions foraggregation and beta-sheet growth velocities, we predict a multi-phasicbehavior of proteins/peptides in response to varying kinetic parameters. Ourmodel also captures other interesting aspects of amyloid growth includingthe potential of growing fibrils to generate mechanical forces and the experi-mentally observed phenomenon of intermittent nature of filament growth.Overall, the study could significantly augment our fundamental understandingof the complex phenomenon of amyloid aggregation.1095-Pos Board B72Biophysical Insight of DNA Induced Aggregation of Stem BromelainMasihuz Zaman, Rizwan Hasan Khan.Biotechnology, Aligarh Muslim University, Aligarh, India.Stembromelain,awidelyacceptedphytotherapeuticaldrug,existsasapartiallyfoldedintermediateatpH2.0,conditionalsoencounteredinthegastrointestinaltract (its site of adsorption). Numerous studies have demonstrated that variousenvironmental and intracellular factors affect the fibrillation property of stembromelain, by accelerating the process of assembly. In this study, the effectof calf thymus DNA (CT-DNA) on stem bromelain is investigated using mul-tiple approaches such as turbidity measurements, ANS binding assays, Ray-leigh scattering, ThT binding, far-UV circular dichroism, dynamic lightscattering fluorescence microscopy and transmission electron microscopy.CT-DNA induced large sized b-sheet aggregates of SB at pH 2.0, and propen-sity of aggregation concomitantly increases with increasing concentration ofCT-DNA (0-100mM) followedby saturation phase at higherCT-DNA concen-tration. Furthermore, isothermal titration calorimetric measurements suggestedthatelectrostaticinteractionbetweenpositivelychargedSBatpH2.0andnega-tively charged phosphate group of CT-DNA is the probable mechanism thatleads to aggregate formation. However, the hydrophobic interaction betweenCT-DNA and SB cannot be neglected.